エビ病治療薬 - 世界市場シェア・ランキング、全体売上高・需要予測 2024-2030Shrimp's Disease Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030 エビ病治療薬の世界市場は、2023年には100万米ドル規模と推定され、2024〜2030年の予測期間中にCAGR %で2030年には100万米ドルに再調整されると予測されている。 世界の医薬品市場は2022年に1,475億米ドルとなり... もっと見る
※当ページの内容はウェブ更新時の情報です。
サマリーエビ病治療薬の世界市場は、2023年には100万米ドル規模と推定され、2024〜2030年の予測期間中にCAGR %で2030年には100万米ドルに再調整されると予測されている。世界の医薬品市場は2022年に1,475億米ドルとなり、今後6年間のCAGRは5%で成長する。医薬品市場には、化学医薬品と生物学的製剤が含まれる。生物製剤は2022年に3810億米ドルになると予想されている。これに対し、化学医薬品市場は2018年の1,050億米ドルから2022年には1,090億米ドルに増加すると推定されている。医薬品市場の要因としては、医療需要の増加、技術の進歩、慢性疾患の有病率の上昇、医薬品製造分野の開発に対する民間&政府機関からの資金提供の増加、医薬品の研究開発活動の活発化などが挙げられる。しかし、厳しい規制、研究開発費の高騰、特許切れといった課題にも直面している。企業は、市場での競争力を維持し、必要としている患者に確実に製品を届けるために、継続的に技術革新を行い、こうした課題に適応していく必要がある。さらに、COVID-19の大流行はワクチン開発とサプライチェーン管理の重要性を浮き彫りにし、製薬企業が新たな公衆衛生のニーズに機敏に対応する必要性をさらに強調している。 レポートの範囲 本レポートは、エビ病治療薬の世界市場を包括的に紹介することを目的としており、地域別・国別、タイプ別、用途別のエビ病治療薬の分析とともに、総売上高、主要企業の市場シェア、ランキングに焦点を当てています。 エビ病治療薬の市場規模、推計、予測は、2023年を基準年とし、2019年から2030年までの期間の履歴データと予測データを売上高(百万ドル)で提供します。定量分析および定性分析により、読者がビジネス/成長戦略を策定し、市場競争状況を評価し、現在の市場における自社のポジションを分析し、エビ病治療薬に関する十分な情報に基づいたビジネス上の意思決定を行えるよう支援します。 市場区分 企業別 アクセンティブ アージェントラブズリミテッド シンデル ファームゲート ファイザー ビメダ社 メルク社 アクアタクティクス ゾエティス社 バイエル ヘルスケアLLC アニマルヘルス部門 タイプ別セグメント ホルマリン溶液 塩化ベンザルコニウム 抗生物質 その他 用途別セグメント アクアリウムショップ オンライン薬局 その他 地域別 北米 アメリカ カナダ 欧州 ドイツ フランス 英国 イタリア ロシア アジア太平洋 中国 日本 韓国 中国 台湾 東南アジア インド ラテンアメリカ メキシコ ブラジル アルゼンチン 中東・アフリカ トルコ サウジアラビア アラブ首長国連邦 各章の概要 第1章: レポートのスコープ、世界の総市場規模を紹介。本章ではまた、市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を提供します。 第2章:エビ病治療メーカーの競争環境、収益市場シェア、最新の開発計画、合併・買収情報などを詳細に分析。 第3章:様々な市場セグメントをタイプ別に分析し、各市場セグメントの市場規模や発展の可能性を網羅し、読者が様々な市場セグメントにおけるブルーオーシャン市場を見つけるのに役立ちます。 第4章:アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの市場規模と発展の可能性をカバーし、読者が異なる川下市場のブルーオーシャン市場を見つけるのに役立ちます。 第5章:地域レベルでのエビ病治療薬の収益。各地域の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展見込み、市場空間、市場規模を紹介しています。 第6章:エビ病治療薬の国別売上高各国・地域のタイプ別、用途別のシグメイトデータを提供しています。 第7章:主要企業のプロフィールを提供し、製品収益、粗利益率、製品紹介、最近の開発など、市場における主要企業の基本的な状況を詳細に紹介する。 第8章:産業の上流と下流を含む産業チェーンの分析。 第9章:結論 目次1 Market Overview1.1 Shrimp's Disease Treatment Product Introduction 1.2 Global Shrimp's Disease Treatment Market Size Forecast 1.3 Shrimp's Disease Treatment Market Trends & Drivers 1.3.1 Shrimp's Disease Treatment Industry Trends 1.3.2 Shrimp's Disease Treatment Market Drivers & Opportunity 1.3.3 Shrimp's Disease Treatment Market Challenges 1.3.4 Shrimp's Disease Treatment Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Shrimp's Disease Treatment Players Revenue Ranking (2023) 2.2 Global Shrimp's Disease Treatment Revenue by Company (2019-2024) 2.3 Key Companies Shrimp's Disease Treatment Manufacturing Base Distribution and Headquarters 2.4 Key Companies Shrimp's Disease Treatment Product Offered 2.5 Key Companies Time to Begin Mass Production of Shrimp's Disease Treatment 2.6 Shrimp's Disease Treatment Market Competitive Analysis 2.6.1 Shrimp's Disease Treatment Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Shrimp's Disease Treatment Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Shrimp's Disease Treatment as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Formalin Solution 3.1.2 Benzalkonium Chloride 3.1.3 Antibiotic 3.1.4 Others 3.2 Global Shrimp's Disease Treatment Sales Value by Type 3.2.1 Global Shrimp's Disease Treatment Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Shrimp's Disease Treatment Sales Value, by Type (2019-2030) 3.2.3 Global Shrimp's Disease Treatment Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Aquarium Shop 4.1.2 Online Pharmacy 4.1.3 Others 4.2 Global Shrimp's Disease Treatment Sales Value by Application 4.2.1 Global Shrimp's Disease Treatment Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Shrimp's Disease Treatment Sales Value, by Application (2019-2030) 4.2.3 Global Shrimp's Disease Treatment Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Shrimp's Disease Treatment Sales Value by Region 5.1.1 Global Shrimp's Disease Treatment Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Shrimp's Disease Treatment Sales Value by Region (2019-2024) 5.1.3 Global Shrimp's Disease Treatment Sales Value by Region (2025-2030) 5.1.4 Global Shrimp's Disease Treatment Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Shrimp's Disease Treatment Sales Value, 2019-2030 5.2.2 North America Shrimp's Disease Treatment Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Shrimp's Disease Treatment Sales Value, 2019-2030 5.3.2 Europe Shrimp's Disease Treatment Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Shrimp's Disease Treatment Sales Value, 2019-2030 5.4.2 Asia Pacific Shrimp's Disease Treatment Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Shrimp's Disease Treatment Sales Value, 2019-2030 5.5.2 South America Shrimp's Disease Treatment Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Shrimp's Disease Treatment Sales Value, 2019-2030 5.6.2 Middle East & Africa Shrimp's Disease Treatment Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Shrimp's Disease Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Shrimp's Disease Treatment Sales Value 6.3 United States 6.3.1 United States Shrimp's Disease Treatment Sales Value, 2019-2030 6.3.2 United States Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Shrimp's Disease Treatment Sales Value, 2019-2030 6.4.2 Europe Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Shrimp's Disease Treatment Sales Value, 2019-2030 6.5.2 China Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.5.3 China Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Shrimp's Disease Treatment Sales Value, 2019-2030 6.6.2 Japan Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Shrimp's Disease Treatment Sales Value, 2019-2030 6.7.2 South Korea Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Shrimp's Disease Treatment Sales Value, 2019-2030 6.8.2 Southeast Asia Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Shrimp's Disease Treatment Sales Value, 2019-2030 6.9.2 India Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.9.3 India Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 AXCENTIVE 7.1.1 AXCENTIVE Profile 7.1.2 AXCENTIVE Main Business 7.1.3 AXCENTIVE Shrimp's Disease Treatment Products, Services and Solutions 7.1.4 AXCENTIVE Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.1.5 AXCENTIVE Recent Developments 7.2 ArgentLabs Limited 7.2.1 ArgentLabs Limited Profile 7.2.2 ArgentLabs Limited Main Business 7.2.3 ArgentLabs Limited Shrimp's Disease Treatment Products, Services and Solutions 7.2.4 ArgentLabs Limited Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.2.5 ArgentLabs Limited Recent Developments 7.3 Syndel 7.3.1 Syndel Profile 7.3.2 Syndel Main Business 7.3.3 Syndel Shrimp's Disease Treatment Products, Services and Solutions 7.3.4 Syndel Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.3.5 Pharmgate Recent Developments 7.4 Pharmgate 7.4.1 Pharmgate Profile 7.4.2 Pharmgate Main Business 7.4.3 Pharmgate Shrimp's Disease Treatment Products, Services and Solutions 7.4.4 Pharmgate Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.4.5 Pharmgate Recent Developments 7.5 Pfizer Inc. 7.5.1 Pfizer Inc. Profile 7.5.2 Pfizer Inc. Main Business 7.5.3 Pfizer Inc. Shrimp's Disease Treatment Products, Services and Solutions 7.5.4 Pfizer Inc. Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.5.5 Pfizer Inc. Recent Developments 7.6 Bimeda, Inc. 7.6.1 Bimeda, Inc. Profile 7.6.2 Bimeda, Inc. Main Business 7.6.3 Bimeda, Inc. Shrimp's Disease Treatment Products, Services and Solutions 7.6.4 Bimeda, Inc. Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.6.5 Bimeda, Inc. Recent Developments 7.7 Merck & Co, Inc 7.7.1 Merck & Co, Inc Profile 7.7.2 Merck & Co, Inc Main Business 7.7.3 Merck & Co, Inc Shrimp's Disease Treatment Products, Services and Solutions 7.7.4 Merck & Co, Inc Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.7.5 Merck & Co, Inc Recent Developments 7.8 AquaTactics 7.8.1 AquaTactics Profile 7.8.2 AquaTactics Main Business 7.8.3 AquaTactics Shrimp's Disease Treatment Products, Services and Solutions 7.8.4 AquaTactics Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.8.5 AquaTactics Recent Developments 7.9 Zoetis Inc. 7.9.1 Zoetis Inc. Profile 7.9.2 Zoetis Inc. Main Business 7.9.3 Zoetis Inc. Shrimp's Disease Treatment Products, Services and Solutions 7.9.4 Zoetis Inc. Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.9.5 Zoetis Inc. Recent Developments 7.10 Bayer HealthCareLLC 7.10.1 Bayer HealthCareLLC Profile 7.10.2 Bayer HealthCareLLC Main Business 7.10.3 Bayer HealthCareLLC Shrimp's Disease Treatment Products, Services and Solutions 7.10.4 Bayer HealthCareLLC Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.10.5 Bayer HealthCareLLC Recent Developments 7.11 Animal Health Division 7.11.1 Animal Health Division Profile 7.11.2 Animal Health Division Main Business 7.11.3 Animal Health Division Shrimp's Disease Treatment Products, Services and Solutions 7.11.4 Animal Health Division Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.11.5 Animal Health Division Recent Developments 8 Industry Chain Analysis 8.1 Shrimp's Disease Treatment Industrial Chain 8.2 Shrimp's Disease Treatment Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Shrimp's Disease Treatment Sales Model 8.5.2 Sales Channel 8.5.3 Shrimp's Disease Treatment Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
SummaryThe global market for Shrimp's Disease Treatment was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030. Table of Contents1 Market Overview1.1 Shrimp's Disease Treatment Product Introduction 1.2 Global Shrimp's Disease Treatment Market Size Forecast 1.3 Shrimp's Disease Treatment Market Trends & Drivers 1.3.1 Shrimp's Disease Treatment Industry Trends 1.3.2 Shrimp's Disease Treatment Market Drivers & Opportunity 1.3.3 Shrimp's Disease Treatment Market Challenges 1.3.4 Shrimp's Disease Treatment Market Restraints 1.4 Assumptions and Limitations 1.5 Study Objectives 1.6 Years Considered 2 Competitive Analysis by Company 2.1 Global Shrimp's Disease Treatment Players Revenue Ranking (2023) 2.2 Global Shrimp's Disease Treatment Revenue by Company (2019-2024) 2.3 Key Companies Shrimp's Disease Treatment Manufacturing Base Distribution and Headquarters 2.4 Key Companies Shrimp's Disease Treatment Product Offered 2.5 Key Companies Time to Begin Mass Production of Shrimp's Disease Treatment 2.6 Shrimp's Disease Treatment Market Competitive Analysis 2.6.1 Shrimp's Disease Treatment Market Concentration Rate (2019-2024) 2.6.2 Global 5 and 10 Largest Companies by Shrimp's Disease Treatment Revenue in 2023 2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Shrimp's Disease Treatment as of 2023) 2.7 Mergers & Acquisitions, Expansion 3 Segmentation by Type 3.1 Introduction by Type 3.1.1 Formalin Solution 3.1.2 Benzalkonium Chloride 3.1.3 Antibiotic 3.1.4 Others 3.2 Global Shrimp's Disease Treatment Sales Value by Type 3.2.1 Global Shrimp's Disease Treatment Sales Value by Type (2019 VS 2023 VS 2030) 3.2.2 Global Shrimp's Disease Treatment Sales Value, by Type (2019-2030) 3.2.3 Global Shrimp's Disease Treatment Sales Value, by Type (%) (2019-2030) 4 Segmentation by Application 4.1 Introduction by Application 4.1.1 Aquarium Shop 4.1.2 Online Pharmacy 4.1.3 Others 4.2 Global Shrimp's Disease Treatment Sales Value by Application 4.2.1 Global Shrimp's Disease Treatment Sales Value by Application (2019 VS 2023 VS 2030) 4.2.2 Global Shrimp's Disease Treatment Sales Value, by Application (2019-2030) 4.2.3 Global Shrimp's Disease Treatment Sales Value, by Application (%) (2019-2030) 5 Segmentation by Region 5.1 Global Shrimp's Disease Treatment Sales Value by Region 5.1.1 Global Shrimp's Disease Treatment Sales Value by Region: 2019 VS 2023 VS 2030 5.1.2 Global Shrimp's Disease Treatment Sales Value by Region (2019-2024) 5.1.3 Global Shrimp's Disease Treatment Sales Value by Region (2025-2030) 5.1.4 Global Shrimp's Disease Treatment Sales Value by Region (%), (2019-2030) 5.2 North America 5.2.1 North America Shrimp's Disease Treatment Sales Value, 2019-2030 5.2.2 North America Shrimp's Disease Treatment Sales Value by Country (%), 2023 VS 2030 5.3 Europe 5.3.1 Europe Shrimp's Disease Treatment Sales Value, 2019-2030 5.3.2 Europe Shrimp's Disease Treatment Sales Value by Country (%), 2023 VS 2030 5.4 Asia Pacific 5.4.1 Asia Pacific Shrimp's Disease Treatment Sales Value, 2019-2030 5.4.2 Asia Pacific Shrimp's Disease Treatment Sales Value by Country (%), 2023 VS 2030 5.5 South America 5.5.1 South America Shrimp's Disease Treatment Sales Value, 2019-2030 5.5.2 South America Shrimp's Disease Treatment Sales Value by Country (%), 2023 VS 2030 5.6 Middle East & Africa 5.6.1 Middle East & Africa Shrimp's Disease Treatment Sales Value, 2019-2030 5.6.2 Middle East & Africa Shrimp's Disease Treatment Sales Value by Country (%), 2023 VS 2030 6 Segmentation by Key Countries/Regions 6.1 Key Countries/Regions Shrimp's Disease Treatment Sales Value Growth Trends, 2019 VS 2023 VS 2030 6.2 Key Countries/Regions Shrimp's Disease Treatment Sales Value 6.3 United States 6.3.1 United States Shrimp's Disease Treatment Sales Value, 2019-2030 6.3.2 United States Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.3.3 United States Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 6.4 Europe 6.4.1 Europe Shrimp's Disease Treatment Sales Value, 2019-2030 6.4.2 Europe Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.4.3 Europe Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 6.5 China 6.5.1 China Shrimp's Disease Treatment Sales Value, 2019-2030 6.5.2 China Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.5.3 China Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 6.6 Japan 6.6.1 Japan Shrimp's Disease Treatment Sales Value, 2019-2030 6.6.2 Japan Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.6.3 Japan Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 6.7 South Korea 6.7.1 South Korea Shrimp's Disease Treatment Sales Value, 2019-2030 6.7.2 South Korea Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.7.3 South Korea Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 6.8 Southeast Asia 6.8.1 Southeast Asia Shrimp's Disease Treatment Sales Value, 2019-2030 6.8.2 Southeast Asia Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.8.3 Southeast Asia Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 6.9 India 6.9.1 India Shrimp's Disease Treatment Sales Value, 2019-2030 6.9.2 India Shrimp's Disease Treatment Sales Value by Type (%), 2023 VS 2030 6.9.3 India Shrimp's Disease Treatment Sales Value by Application, 2023 VS 2030 7 Company Profiles 7.1 AXCENTIVE 7.1.1 AXCENTIVE Profile 7.1.2 AXCENTIVE Main Business 7.1.3 AXCENTIVE Shrimp's Disease Treatment Products, Services and Solutions 7.1.4 AXCENTIVE Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.1.5 AXCENTIVE Recent Developments 7.2 ArgentLabs Limited 7.2.1 ArgentLabs Limited Profile 7.2.2 ArgentLabs Limited Main Business 7.2.3 ArgentLabs Limited Shrimp's Disease Treatment Products, Services and Solutions 7.2.4 ArgentLabs Limited Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.2.5 ArgentLabs Limited Recent Developments 7.3 Syndel 7.3.1 Syndel Profile 7.3.2 Syndel Main Business 7.3.3 Syndel Shrimp's Disease Treatment Products, Services and Solutions 7.3.4 Syndel Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.3.5 Pharmgate Recent Developments 7.4 Pharmgate 7.4.1 Pharmgate Profile 7.4.2 Pharmgate Main Business 7.4.3 Pharmgate Shrimp's Disease Treatment Products, Services and Solutions 7.4.4 Pharmgate Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.4.5 Pharmgate Recent Developments 7.5 Pfizer Inc. 7.5.1 Pfizer Inc. Profile 7.5.2 Pfizer Inc. Main Business 7.5.3 Pfizer Inc. Shrimp's Disease Treatment Products, Services and Solutions 7.5.4 Pfizer Inc. Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.5.5 Pfizer Inc. Recent Developments 7.6 Bimeda, Inc. 7.6.1 Bimeda, Inc. Profile 7.6.2 Bimeda, Inc. Main Business 7.6.3 Bimeda, Inc. Shrimp's Disease Treatment Products, Services and Solutions 7.6.4 Bimeda, Inc. Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.6.5 Bimeda, Inc. Recent Developments 7.7 Merck & Co, Inc 7.7.1 Merck & Co, Inc Profile 7.7.2 Merck & Co, Inc Main Business 7.7.3 Merck & Co, Inc Shrimp's Disease Treatment Products, Services and Solutions 7.7.4 Merck & Co, Inc Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.7.5 Merck & Co, Inc Recent Developments 7.8 AquaTactics 7.8.1 AquaTactics Profile 7.8.2 AquaTactics Main Business 7.8.3 AquaTactics Shrimp's Disease Treatment Products, Services and Solutions 7.8.4 AquaTactics Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.8.5 AquaTactics Recent Developments 7.9 Zoetis Inc. 7.9.1 Zoetis Inc. Profile 7.9.2 Zoetis Inc. Main Business 7.9.3 Zoetis Inc. Shrimp's Disease Treatment Products, Services and Solutions 7.9.4 Zoetis Inc. Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.9.5 Zoetis Inc. Recent Developments 7.10 Bayer HealthCareLLC 7.10.1 Bayer HealthCareLLC Profile 7.10.2 Bayer HealthCareLLC Main Business 7.10.3 Bayer HealthCareLLC Shrimp's Disease Treatment Products, Services and Solutions 7.10.4 Bayer HealthCareLLC Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.10.5 Bayer HealthCareLLC Recent Developments 7.11 Animal Health Division 7.11.1 Animal Health Division Profile 7.11.2 Animal Health Division Main Business 7.11.3 Animal Health Division Shrimp's Disease Treatment Products, Services and Solutions 7.11.4 Animal Health Division Shrimp's Disease Treatment Revenue (US$ Million) & (2019-2024) 7.11.5 Animal Health Division Recent Developments 8 Industry Chain Analysis 8.1 Shrimp's Disease Treatment Industrial Chain 8.2 Shrimp's Disease Treatment Upstream Analysis 8.2.1 Key Raw Materials 8.2.2 Raw Materials Key Suppliers 8.2.3 Manufacturing Cost Structure 8.3 Midstream Analysis 8.4 Downstream Analysis (Customers Analysis) 8.5 Sales Model and Sales Channels 8.5.1 Shrimp's Disease Treatment Sales Model 8.5.2 Sales Channel 8.5.3 Shrimp's Disease Treatment Distributors 9 Research Findings and Conclusion 10 Appendix 10.1 Research Methodology 10.1.1 Methodology/Research Approach 10.1.2 Data Source 10.2 Author Details 10.3 Disclaimer
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療/ヘルスケア)の最新刊レポート
QYResearch社の医薬・ヘルスケア分野での最新刊レポート本レポートと同じKEY WORD()の最新刊レポート
よくあるご質問QYResearch社はどのような調査会社ですか?QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|